NDC 0574-0229 – Benazepril hydrochloride and hydrochlorothiazide

Benazepril Hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC0574-0229

Product details

Brand name
Benazepril hydrochloride and hydrochlorothiazide
Generic name
Benazepril hydrochloride and hydrochlorothiazide
Labeler
Padagis US LLC
Dosage form
Tablet
Route
Oral
Marketing category
NDA AUTHORIZED GENERIC · NDA020033
Marketed since
April 7, 2019
Marketing end
September 30, 2027
Pharmacologic class
Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Active ingredients

Uses, dosage, side effects and warnings for Benazepril hydrochloride and hydrochlorothiazide →

Package NDC codes (1)

Package NDCDescriptionSince
0574-0229-01100 TABLET in 1 BOTTLE (0574-0229-01)Apr 7, 2019

Other Benazepril hydrochloride and hydrochlorothiazide products